Literature DB >> 8360888

Application of a conformationally restricted Phe-Leu dipeptide mimetic to the design of a combined inhibitor of angiotensin I-converting enzyme and neutral endopeptidase 24.11.

G A Flynn1, D W Beight, S Mehdi, J R Koehl, E L Giroux, J F French, P W Hake, R C Dage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8360888     DOI： 10.1021/jm00068a022

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  2 in total

1.  Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.

Authors:  M C Fournié-Zaluski; W Gonzalez; S Turcaud; I Pham; B P Roques; J B Michel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 2.  The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.

Authors:  Massimo Volpe; Marino Carnovali; Vittoria Mastromarino
Journal:  Clin Sci (Lond)       Date:  2016-01       Impact factor: 6.124
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.